News Express: UM scholar gives talk on Chinese medicine in cancer therapy
新聞快訊：澳大學人分享中藥抗癌研究
陸金健
Lu Jinjian
澳大學人分享中藥抗癌研究
澳門大學今（25）日舉行“澳大學人研究講壇”第24講，由澳大中華醫藥研究院教授陸金健以“免疫微環境：中藥抗癌新視角”為題，分享其在相關領域的深入研究成果。講座現場反應熱烈，亦有不少中學師生以線上形式參與。
講座上，陸金健介紹了中藥在抗癌領域的悠久歷史和潛在應用價值。他重點講述了其團隊近年發現的中藥來源人參皂苷Rh2與三葉青多糖如何增強免疫治療抗癌效果，並揭示了兩者在調節腫瘤免疫微環境時所展現出的獨特機制和共通之處。是次講座不僅展示了其最新研究成果，也為與會者提供了和傑出學者交流的機會，加深了他們對中藥在免疫微環境中抗癌作用的理解。
陸金健長期從事中藥抗癌化合物發現及機制研究，擁有豐富的學術經驗和研究成果。他曾在SCI期刊上發表多篇論文，獲澳門科學技術獎自然科學獎二等獎等諸多獎項，並任澳門精準醫學學會副理事長。
“澳大學人研究講壇”由澳大研究服務及知識轉移辦公室舉辦，旨在邀請傑出的澳大學人以通俗易懂的方式介紹其前沿研究成果，引導大眾和青年學生了解研究創新的社會意義和價值，以及與日常生活密切關聯的應用性，提升大眾和青年學生的科學素養。
欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/press-release/detail/60405/
UM scholar gives talk on Chinese medicine in cancer therapy
The University of Macau (UM) held the 24th UM Scholar Research Forum today (25 February), with Lu Jinjian, professor in the UM Institute of Chinese Medical Sciences (ICMS), as the speaker. Prof Lu gave a talk titled ‘Immune Microenvironment: A New Perspective on Chinese Medicine in Cancer Therapy’ to share his research findings. The talk attracted a full house, with many secondary school students and teachers attending online.
During the talk, Prof Lu discussed the long history and potential applications of Chinese medicine in cancer treatment. He shared his team’s recent discovery of how ginsenoside Rh2 and Tetrastigma hemsleyanum polysaccharides, compounds derived from Chinese medicine, enhance the efficacy of immunotherapy. He also explained the unique mechanisms and commonalities of these two substances in modulating the tumour immune microenvironment. The talk deepened the participants’ understanding of the role of Chinese medicine in tumour immune microenvironment.
To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/60405/